ACSL4 and urogenital neoplasm: Similarly, given the sensitivity of ACSL4 as a promotor of lipid peroxidation, an initial study demonstrated that targeting inhibition of ACSL4 via dexmedetomidine protect kidneys against IRI-induced kidney injury [249] (Fig. 7).